Catalysts for Ridgeback Biotherapeutics LLC
5 tracked
Feb 18, 2026
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 26, 2024
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
May 19, 2022
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 7, 2021
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 21, 2020
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→